市場調査レポート

商品コード

1593463

ファーマコビジランスと医薬品安全性ソフトウェアの市場規模、シェア、成長分析、機能別、展開モード別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Pharmacovigilance and Drug Safety Software Market Size, Share, Growth Analysis, By Functionality, By Deployment Mode, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年11月11日
発行: SkyQuest
ページ情報: 英文 207 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ファーマコビジランスと医薬品安全性ソフトウェアの世界市場規模は2022年に1億8,230万米ドルと評価され、2023年の1億9,433万米ドルから2031年には3億2,404万米ドルに成長し、予測期間（2024-2031年）のCAGRは10.5%で成長する見込みです。

世界のファーマコビジランスと医薬品安全性ソフトウェア市場は、医薬品副作用（ADR）やその他の安全性問題の追跡、分析、報告を強化することを目的とした専門プログラムで構成されており、特にルーマニアでは、ヘルスケアプロバイダーや規制当局にとってますます不可欠なものとなっています。これらのソフトウェアツールは、医薬品の安全性に関する広範なデータの効率的な収集、管理、分析を可能にし、製薬会社やヘルスケア専門家による投薬の有効性や副作用のモニタリングを支援します。潜在的なリスクや新たな動向を特定することで、タイムリーな介入やリスク軽減戦略を促進します。これらのソリューションの主なユーザーには、大手ファーマコビジランスプロバイダー、ビジネスプロセスアウトソーシング（BPO）企業、医薬品開発業務受託機関（CRO）などが含まれます。市場が発展するにつれ、ADRの発生率の上昇や組織間のアウトソーシング傾向の高まりなど、複数の力学の影響を受けるようになり、これが採用率を押し上げると予想されます。さらに、FDAやEMEAなどの規制当局が医薬品の安全基準の強化を求めるようになったことも、この分野の成長に拍車をかけています。その結果、ファーマコビジランスと医薬品安全性ソフトウェア市場は、安全な薬物療法の実践と薬物関連リスクの効果的な管理の必要性による大幅な拡大を特徴とする、有望な将来に向けて準備されています。

北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東およびアフリカ
- アラブ首長国連邦諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Oracle Corporation
Veeva Systems Inc.
AB-Cube
ArisGlobal

Product Code: SQMIG35G2302

Global Pharmacovigilance and Drug Safety Software Market size was valued at USD 182.3 Million in 2022 poised to grow from USD 194.33 Million in 2023 to USD 324.04 Million by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

The global pharmacovigilance and drug safety software market, which consists of specialized programs aimed at enhancing the tracking, analysis, and reporting of Adverse Drug Reactions (ADRs) and other safety issues, is increasingly vital for healthcare providers and regulatory agencies, particularly in Romania. These software tools enable efficient collection, management, and analysis of extensive data concerning drug safety, assisting pharmaceutical companies and healthcare professionals in monitoring medication effectiveness and side effects. By identifying potential risks and emerging trends, they facilitate timely interventions and risk mitigation strategies. Primary users of these solutions include large pharmacovigilance providers, business process outsourcing (BPO) firms, and contract research organizations (CROs). As the market evolves, it is influenced by multiple dynamics, including the rising incidence of ADRs and the growing trend of outsourcing among organizations, which is expected to propel adoption rates. Moreover, increased regulatory scrutiny from agencies such as the FDA and EMEA demanding heightened safety standards in pharmaceuticals is further fueling growth in this sector. Consequently, the pharmacovigilance and drug safety software market is poised for a promising future, characterized by significant expansion driven by the necessity for safe medication practices and the effective management of drug-related risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmacovigilance And Drug Safety Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacovigilance And Drug Safety Software Market Segmental Analysis

Global Pharmacovigilance and Drug Safety Software Market is segmented by Function, Deployment Mode, End User and region. Based on Function, the market is segmented into Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software and Fully Integrated Software Based on Deployment Mode, the market is segmented into On Premise and Cloud. Based on end user, the market is segmented into Pharma and Biotech Companies, Contract Research Organizations, Business Process Outsourcing and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Pharmacovigilance And Drug Safety Software Market

The escalating demand for pharmacovigilance and drug safety software is primarily propelled by stringent global regulatory frameworks enforced by authorities such as the FDA and EMA. These regulations mandate rigorous adverse event reporting and continuous drug safety monitoring, compelling pharmaceutical companies to adopt reliable software solutions that streamline compliance processes. As the drug development landscape becomes increasingly complex, the need for scalable and effective pharmacovigilance systems intensifies, enabling firms to efficiently manage regulatory obligations, mitigate risks, and enhance patient safety. This growing emphasis on regulatory adherence not only drives innovations in software development but also positions pharmacovigilance solutions as indispensable assets in the pharmaceutical industry.

Restraints in the Global Pharmacovigilance And Drug Safety Software Market

The Global Pharmacovigilance and Drug Safety Software market faces significant restraints due to the complex integration of novel software with existing systems and workflows. This challenge often leads to disruptions in operations, as organizations grapple with data migration issues to ensure compatibility with older systems that may lack modern efficiencies. Additionally, the high costs associated with advanced solutions deter many companies from adopting these technologies, resulting in prolonged implementation timelines. Consequently, the reluctance to invest in and transition to more effective pharmacovigilance tools curtails market growth, as businesses weigh the operational hassles against the benefits of new solutions.

Market Trends of the Global Pharmacovigilance And Drug Safety Software Market

The global pharmacovigilance and drug safety software market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning technologies. These advancements facilitate superior data analytics, enabling more efficient automation of adverse event reporting and enhanced predictive capabilities. As a result, stakeholders can achieve improved accuracy and efficacy in drug safety management, leading to better compliance with regulatory standards. This trend reflects a broader shift towards digitization and automation within the healthcare sector, fostering a proactive approach to drug safety and risk management, ultimately ensuring the protection of public health and enhancing pharmaceutical innovation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Technological Advancement
Regulatory Landscape
Patent Analysis
Value Chain Analysis
Case Study Analysis
PESTEL Analysis
Macro-Economic Indicators
Trade Analysis
Startup Analysis
Supply Chain Analysis
Pricing Analysis

Global Pharmacovigilance and Drug Safety Software Market Size by Function & CAGR (2024-2031)

Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software

Global Pharmacovigilance and Drug Safety Software Market Size by Deployment Mode & CAGR (2024-2031)

On Premise
On Cloud

Global Pharmacovigilance and Drug Safety Software Market Size by End User & CAGR (2024-2031)

Pharma and Biotech Companies
Contract Research Organizations
Business Process Outsourcing
Other

Global Pharmacovigilance and Drug Safety Software Market Size & CAGR (2024-2031)

North America, (Function, Deployment Mode, End User)
- US
- Canada
Europe, (Function, Deployment Mode, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Function, Deployment Mode, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Function, Deployment Mode, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Function, Deployment Mode, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Oracle Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veeva Systems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AB-Cube
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArisGlobal
- Company Overview
- Business Segment Overview

ファーマコビジランスと医薬品安全性ソフトウェアの市場規模、シェア、成長分析、機能別、展開モード別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Pharmacovigilance and Drug Safety Software Market Size, Share, Growth Analysis, By Functionality, By Deployment Mode, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

ファーマコビジランスと医薬品安全性ソフトウェア市場：機能別

ファーマコビジランスと医薬品安全性ソフトウェア市場：展開モード別

ファーマコビジランスと医薬品安全性ソフトウェア市場：エンドユーザー別

ファーマコビジランスと医薬品安全性ソフトウェア市場規模：地域別